Posted inBusiness Insights
Piramal Pharma Braces for Massive ₹1,750 Crore Block Deal as Shares Edge Higher
Piramal Pharma shares rise as investors brace for a massive 1750 crore block deal with a major six percent stake sale on the horizon.
Posted inBusiness Insights
Cipla Secures US FDA Approval for Generic Advair Diskus Across All Strengths
Indian pharmaceutical major Cipla Limited has secured final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for generic Advair Diskus. The regulatory clearance…
Posted inBusiness Insights
NBCC Secures ₹109 Crore Infrastructure Orders for Odisha Hostels and Srinagar Laboratory
State-owned construction giant NBCC (India) Limited has secured fresh work orders worth ₹109 crore for major infrastructure projects spanning Odisha and Srinagar. The public sector enterprise announced the developments as…
Posted inBusiness Insights
Aurobindo Pharma Secures Merck Licensing Deal to Expand Generic HIV Drug Access Across 129 Nations
Indian pharmaceutical major Aurobindo Pharma Limited has signed a strategic voluntary licensing agreement with US-based Merck & Co. to manufacture and supply generic versions of a key HIV drug across…
Posted inBusiness Insights
Piramal Pharma Pauses Ahmedabad Operations Amid Severe Gujarat Monsoon Flooding
Piramal Pharma Limited temporarily halted operations at its primary manufacturing facility in Ahmedabad, Gujarat, this week following intense monsoonal downpours that inundated parts of the industrial site. The precautionary shutdown…
Posted inMarket
Caliber Mining and Logistics Debuts at 19% Premium Before Volatility Erases Early Gains
Caliber Mining and Logistics made its debut on Indian stock exchanges today, opening at ₹504 on the Bombay Stock Exchange (BSE)—a 19 percent premium over its issue price of ₹424—and…
Posted inBusiness Insights
Motilal Oswal Reports Strong Q1 Operating Profit Growth Driven by 31% Surge in AUM
Motilal Oswal Financial Services Ltd (MOFSL) delivered a robust financial performance for the first quarter of the fiscal year, driven largely by a 31% year-on-year surge in Assets Under Management…
Posted inBusiness Insights
Shadowfax Technologies Launches Major 9% Block Deal at ₹197 Floor Price
Shadowfax Technologies Ltd has initiated a high-profile block deal on the Bombay Stock Exchange (BSE), offering a 9% equity stake at a floor price of ₹197 per share. The transaction…
Posted inBusiness Insights
Shadowfax Technologies Launches Block Deal Offering 9% Stake at ₹197 Floor Price
Institutional investors launched a high-value block deal for logistics provider Shadowfax Technologies Ltd on the Bombay Stock Exchange (BSE), offering a 9% equity stake at a floor price of ₹197…
Posted inBusiness Insights
Shadowfax Technologies Launches 9% Block Deal at ₹197 Floor Price
Shadowfax Technologies launched a high-stakes block deal on the Bombay Stock Exchange (BSE) on Tuesday, offering a 9% equity stake at a floor price of ₹197 per share. The transaction…
